Conferences on June 27, 2012

Renewable Energy Risk Management 2012 Congress and Exhibition

Date: 26-Jun-12 to 27-Jun-12
Location: London / United Kingdom
Renewable Energy Risk Management 2012 26 – 27 June, 2012 London, United Kingdom www.greenpowerconferences.com/riskmanagement Meeting the challenges of a demanding investment marketplace The Renewable Energy industry is growing and maturing as technologies evolve and the market adapts to embrace green energy. With this growth comes an increasing need for investment at a time when appetite for risk is at a historic low. Renewable Energy Risk Management will return to London on 26-27 June The second annual Renewable Energy Risk Management will bring you together with your peers and specialists from the renewable energy insurance community to help you make your projects bankable. With a unique delegation made up of risk-focussed decision makers and advisors, this is an exclusive ...

FDA's new enforcement initiative – Strategic Software Validation Planning for Executives and Managers

Date: 27-Jun-12 to 27-Jun-12
This Software Validation training webinar will discuss how to approach Strategic software Validation planning so as to satisfy FDA by complying to new enforcement initiative by FDA. Why should you Attend: FDA has in place several enforcement initiatives. They are certain to impact your regulatory risk profile. How will you prepare for software quality, software validation and 21 CFR part 11 planning? Extensive use of automated manufacturing, laboratory, QA, QC, complaints, CAPA, Adverse Events systems puts companies at risk. FDA field staff has been trained on software validation and 21 CFR Part 11 inspection and enforcement. Many companies have fallen behind in their software validation practices. Now is the time for forward planning in this crucial area. This executive planning ...

LatinFinance 6th Andean Finance & Investment Forum

Date: 26-Jun-12 to 27-Jun-12
Location: Santiago / Chile
The Andean region has become the rising star in Latin America led by the development of the local capital markets and strong performance by companies across all sectors. The challenges and the solutions to financing this growth will be examined by prominent corporate issuers and local and international institutional investors at the forum, a high level invitation-only LatinFinance summit with interactive panel discussions and debates complemented by private 1-1 meetings for participating delegates.

Africa Insurance &Reinsurance conference

Date: 26-Jun-12 to 27-Jun-12
Location: Nairobi / Kenya
The 2nd Annual Africa Insurance & Reinsurance Conference (AIRC - 2012), will be held in Nairobi Kenya on the 26th - 27th June 2011. The regional as well as global players for discussions and debates that will act as launching pad for much needed innovative products that will shape the feature industry growth trajectory.

Trial Master File for Research Sites: Can You Pass FDA Inspection?

Date: 27-Jun-12 to 27-Jun-12
This webinar on Trial Master File (TMF) for clinical research sites will show how you can create an FDA compliant TMF to ensure that it will pass inspection by FDA investigators and QA Auditors.

Trial Master File for Research Sites: Can You Pass FDA Inspection?

Date: 27-Jun-12 to 27-Jun-12
This webinar on Trial Master File (TMF) for clinical research sites will show how you can create an FDA compliant TMF to ensure that it will pass inspection by FDA investigators and QA Auditors. Why Should You Attend: Your clinical trial has zero chance of passing an FDA inspection or QA audit if your Trial Master File (TMF) is not in order. The FDA frequently states that if compliance isn't documented, it didn't happen. Your TMF serves as living proof that you are adhering to GCP, and that your quality system is in a state of control.

Recalls, Removals, and Market Corrections in Compliance with FDA and ISO Requirements - Webinar By GlobalCompliancePanel

Date: 27-Jun-12 to 27-Jun-12
Overview: To satisfy QSR and ISO 13485 requirements, medical device companies must respond to field reports swiftly and compliantly. There are certain circumstances in which a report from the field requires the device manufacturer to take steps regarding product in the field. It is critical that the company take the required steps in the required timeframes. FDA and ISO requirements overlap to a great extent, but not completely. This webinar sets forth the requirements for recalls, removals, and market corrections, and provides recommended practices. Why should you attend: There are certain circumstances in which a report from the field requires the device manufacturer to take steps regarding product in the field. It is critical that the company take the required steps in the ...

Global Logistics and Cargo Symposium 2012 -GLCS2012

Date: 27-Jun-12 to 28-Jun-12
Location: Kuala Lumpur / Malaysia
MiceVisions’s Global Logistics and Cargo Symposium 2012 is not just an event but it is an opportunity for industry players to network and build coalition that can boost the development of the industry. This event will also provide an opportunity for the delegates to not only listen but to also contribute their views with the decision makers from all sectors of the Logistics and Cargo Industry. It’s a tremendous honor for us to share a master piece of valuable deliverance inspired by the vital and rapid need for progressive development. KEY BENEFITS :- Analyzing the advancement of Economic Transformation Programme (ETP) and its influence Maximizing the growth and market value to help sustain the service consistency for marine industry Examining an applicable technology leverages ...

CSP Today USA 2012

Date: 27-Jun-12 to 28-Jun-12
This event is the only event dedicated 100% to the spearheading the CSP market in the US. With a reputation of excellence, this conference is anticipated to unite over 650 CSP experts in Las Vegas in June 2012.

CANCER VACCINES & ACTIVE IMMUNOTHERAPEUTICS 3RD ANNUAL SUMMIT

Date: 26-Jun-12 to 28-Jun-12
CANCER VACCINES & ACTIVE IMMUNOTHERAPEUTICS 3RD ANNUAL SUMMIT Approaches to Optimize Immune Response, Enhance Clinical Development & Drive Commercial Performance 26 – 28 June 2012 Boston, MA www.cancervaccines-meeting.com Unlock the potential of your anti-cancer drug. Dendreon hit all the headlines when Provenge got approval. Then Ipilimumab. And just beneath the surface, a host of others are starting to make waves. With MAGE, PROSTVAC and several other products knocking on the door of market approval, what are you doing to ensure your drug reaches these heights? Designed by Merck Serono, Immatics Biotechnologies, DCPrime, MedImmune, FDA, Oxford Biomedica and many others, the Cancer Vaccines & Active Immunotherapeutics 3rd Annual Summit will bring together key ...